Micro-Leads Pioneers Medical Breakthrough in a 20 Participant Human Study with HD64, the World's First Spine-ChipSOMERVILLE, MA / ACCESSWIRE / October 1, 2024 / Micro-Leads Inc. today announced the ...
Seasoned Clinical Research Leader to Drive Innovative Solutions for Streamlining Study Start-Ups and Supporting Research SitesMADISON, WI / ACCESSWIRE / October 1, 2024 / Elevate Clinical Research ...
Latest Edition Serves as a Comprehensive Resource for Digital Novices and Experts AlikeNEWPORT BEACH, CA / ACCESSWIRE / ...
NEW YORK, NY / ACCESSWIRE / October 1, 2024 / Dental crowns are caps placed on top of the target tooth, restoring shape and function. Dental veneers are thin coverings that slide over the target tooth ...
AcquisitionLonza Completes Acquisition of Large-Scale Biologics Site in Vacaville (US) from Roche 01.10.2024 / 16:45 CET/CEST The Vacaville site is one of the largest biologics manufacturing ...
Original-Research: Formycon AG - from First Berlin Equity Research GmbH01.10.2024 / 17:05 CET/CESTDissemination of a Research, transmitted by EQS News - a service of EQS Group AG.The issuer is solely ...
KENOSHA, WI / ACCESSWIRE / October 1, 2024 / OccuPro, a leader in employment testing software, proudly announces the release ...
Over 900 healthcare technology experts identified key data systems that fail to deliver ROI and siphon funds from providers after implementation. In 2024, U.S. respondents reported that compounding ...
Ghost job listings appear to advertise available roles, but in reality, don’t reflect an actively available position. Whilst ...
Helios Global Group (“Helios”) has today announced that it has agreed a new investment partnership with Telemos Capital (“Telemos”), a European mid-market private equity firm backed by family capital.
The cooperation between Laxxon and Adare enables the clinical and commercial production of advanced drug delivery systems at Adare’s cGMP facilities in Italy and US NEW YORK CITY, NY / ACCESSWIRE / ...
KELOWNA, BC / ACCESSWIRE / October 1, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX) & (NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces the ...